DJIA 17,976.31 263.65 1.49%
NASDAQ 4,947.44 56.22 1.15%
S&P 500 2,086.24 25.22 1.22%
market minute promo

8.56 0.17 (2.03%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

ARIA $8.56 2.03%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $8.39
Previous Close $8.39
Daily Range $8.39 - $8.69
52-Week Range $4.90 - $9.19
Market Cap $1.6B
P/E Ratio -9.64
Dividend (Yield) $0.00 (0.0%)
Volume 6,519,310
Average Daily Volume 7,145,855
Current FY EPS -$1.05




Drug Makers

Ariad Pharmaceuticals, Inc. (ARIA) Description

The Company is engaged in the discovery and development of breakthrough medicines to treat cancers by regulating cell signaling with small molecules. Website:

News & Commentary

Why Ariad Pharmaceuticals, Inc. Catapulted 26% Higher in February

Ariad Pharmaceuticals' shares rocket to their highest levels since last Spring following a double-dose of positive news for shareholders. Find out whether this momentum can continue.

Big Selloff on Wall Street as Stocks Plummet on Fed Jitters

First Week of ARIA November 20th Options Trading

Health Care Sector Update for 03/24/2015: AERI, PSTI, ARIA

ARIAD and Medison Pharma Announce Approval of Iclusig (Ponatinib) in Israel

Interesting ARIA Call Options For April 10th

What Sarissa Capital's Proxy Fight Means For Ariad Investors

JMP Feeling Mostly Good On 4 Drug, Healthcare Stocks

Seeking Alpha's Biotech Weekly: Sanofi's New Chief, Sarissa Shakes Ariad, And More

Friday's ETF with Unusual Volume: PTH

See More ARIA News...

ARIA's Top Competitors

ARIA $8.56 (2.03%)
Current stock: ARIA
AMGN $164.31 (1.05%)
Current stock: AMGN
BIIB $431.62 (0.41%)
Current stock: BIIB
CELG $120.02 (1.13%)
Current stock: CELG